Cytotoxic and Apoptotic Action of Nonactin and Cephaeline. HBr Precludes Alteration of Redox Status

Author:

Adeyemi Oluyomi Stephen1,Awakan Oluwakemi Josephine1,Adeyanju Anne Adebukola2,Otohinoyi David Adeiza3

Affiliation:

1. Department of Biochemistry, Medicinal Biochemistry, Nanomedicine & Toxicology Laboratory, PMB 1001, Omu-Aran 251101, Nigeria

2. Department of Biochemistry, McPherson University, Lagos-Ibadan Expressway, Seriki-Sotayo, Nigeria

3. School of Medicine, All Saints University, Belair, Kingstown, Dominica

Abstract

Background: Natural products or naturally derived compounds are invaluable to human and animal lives either for nutritional value or for medicinal purposes. Indeed, natural products including extracts containing polychemical mixtures play a leading role in the discovery and development of drugs. However, the increasing interest in natural medicines is also attracting a growing concern about the safety of naturally derived medications. Objective: In the present study, we evaluated several naturally derived compounds for in vitro cytotoxicity in mammalian cells. Methods: A total of 54 compounds were evaluated for in vitro cytotoxic and apoptotic action in Human Fibroblast Foreskin (HFF) cells. Results: Of the 54 natural compounds screened for cellular toxicity, only nonactin and cephaeline. HBr reduced cellular viability by ≥60% with IC50 value <3 µg/ml. Addition of trolox antioxidant to the assay medium failed to abate cellular toxicity by both nonactin and cephaeline.HBr treatments. Fluorescence evaluation for Reactive Oxygen Species (ROS) production as well as Mitochondrial Membrane Potential (MMP) was negative for both nonactin and cephaeline.HBr treatments. In contrast, both nonactin and cephaeline.HBr caused cellular apoptosis and this was not attenuated even in the presence of trolox. Conclusion: Taken together, we show evidence supporting that cytotoxic and apoptotic action of nonactin and cephaeline.HBr precludes oxidative stress or ROS production.

Publisher

Bentham Science Publishers Ltd.

Subject

Complementary and alternative medicine,Drug Discovery

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3